INSP
Inspire Medical Systems Inc
$
128.640
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
131.040
Open
131.040
VWAP
128.65
Vol
540.02K
Mkt Cap
3.79B
Low
127.000
Amount
69.47M
EV/EBITDA(TTM)
59.85
Total Shares
29.71M
EV
3.51B
EV/OCF(TTM)
30.61
P/S(TTM)
4.77
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
214.49M
+9.5%
0.208
-35.06%
240.33M
+18.28%
0.599
-0.24%
292.87M
+22.17%
1.348
+17.18%
Estimates Revision
The market is revising No Change the revenue expectations for Inspire Medical Systems, Inc. (INSP) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -18.69%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+4.48%
In Past 3 Month
Stock Price
Go Down
-18.69%
In Past 3 Month
14 Analyst Rating
67.78% Upside
Wall Street analysts forecast INSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INSP is 215.83 USD with a low forecast of 174.00 USD and a high forecast of 270.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
3 Hold
0 Sell
Strong Buy
67.78% Upside
Current: 128.640
Low
174.00
Averages
215.83
High
270.00
67.78% Upside
Current: 128.640
Low
174.00
Averages
215.83
High
270.00
KeyBanc
Overweight
downgrade
$216 -> $197
2025-07-22
New
Reason
KeyBanc
Price Target
$216 -> $197
2025-07-22
New
downgrade
Overweight
Reason
KeyBanc lowered the firm's price target on Inspire Medical to $197 from $216 and keeps an Overweight rating on the shares. The firm notes that underlying MedTech trends appear positive heading into Q2 earnings season, and KeyBanc believes sub-sector underperformance this year has been more attributable to macro uncertainties such as the impact of tariffs. Specifically, the firm's Key First Look Data has indicated high-single digit volume growth in the hospital category through Q2. KeyBanc continues to view tariffs as the biggest overhang to the group, but consensus estimates at least now incorporate the known base-case impacts.
Morgan Stanley
Overweight
downgrade
$200 -> $182
2025-07-15
Reason
Morgan Stanley
Price Target
$200 -> $182
2025-07-15
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Inspire Medical to $182 from $200 and keeps an Overweight rating on the shares. The firm continues to like the MedTech industry setup into Q2 on relative stability in procedure volumes and hospital capital expenditures across the space, the analyst tells investors in a research note.
Leerink
Market Perform
downgrade
$176 -> $149
2025-07-14
Reason
Leerink
Price Target
$176 -> $149
2025-07-14
downgrade
Market Perform
Reason
Leerink lowered the firm's price target on Inspire Medical to $149 from $176 and keeps a Market Perform rating on the shares ahead of quarterly results. The firm is updating estimates to reflect financial statement disclosures and its updated views, and price targets of several names in the space to reflect recent changes in valuation premiums.
Keybanc
Tim Rezvan
Buy
Maintains
$234 → $216
2025-04-21
Reason
Keybanc
Tim Rezvan
Price Target
$234 → $216
2025-04-21
Maintains
Buy
Reason
KeyBanc lowered the firm's price target on Inspire Medical to $216 from $234 and keeps an Overweight rating on the shares. The firm believes underlying MedTech trends remain mostly positive heading into Q1 earnings season, but is lowering several price targets to reflect macro concerns around the potential impact of tariffs as well as an increased risk of recession.
Stifel
Jonathan Block
Hold
Maintains
$190 → $175
2025-04-21
Reason
Stifel
Jonathan Block
Price Target
$190 → $175
2025-04-21
Maintains
Hold
Reason
RBC Capital
Shagun Singh
Buy
Maintains
$260 → $215
2025-04-15
Reason
RBC Capital
Shagun Singh
Price Target
$260 → $215
2025-04-15
Maintains
Buy
Reason
RBC Capital analyst Shagun Singh lowered the firm's price target on Inspire Medical to $215 from $260 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Medical Devices. Q1 underlying procedure volume and capital placements trends were solid with typical seasonality at play, which should position companies under coverage to beat expectations for the quarter, while FX has moved notably to favor large-cap medical device companies with international exposure, which is not factored into consensus estimates for Q1 or 2025, the analyst tells investors in a research note. Tariff impact is likely to be clarified by several companies, though many companies under coverage have low tariff exposure with a substantial U.S. manufacturing footprint or low relative exposure vs. other large caps, the firm adds.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Inspire Medical Systems Inc (INSP.N) is 51.18, compared to its 5-year average forward P/E of -5.61. For a more detailed relative valuation and DCF analysis to assess Inspire Medical Systems Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-5.61
Current PE
51.18
Overvalued PE
215.96
Undervalued PE
-227.18
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-36.99
Current EV/EBITDA
16.18
Overvalued EV/EBITDA
135.20
Undervalued EV/EBITDA
-209.18
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
14.06
Current PS
3.76
Overvalued PS
21.94
Undervalued PS
6.17
Financials
Annual
Quarterly
FY2025Q1
YoY :
+22.75%
201.32M
Total Revenue
FY2025Q1
YoY :
-90.24%
-1.49M
Operating Profit
FY2025Q1
YoY :
-129.91%
2.99M
Net Income after Tax
FY2025Q1
YoY :
-129.41%
0.10
EPS - Diluted
FY2025Q1
YoY :
+432.79%
-15.11M
Free Cash Flow
FY2025Q1
YoY :
-0.19%
84.75
Gross Profit Margin - %
FY2025Q1
YoY :
+1778.00%
9.39
FCF Margin - %
FY2025Q1
YoY :
-124.43%
1.49
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
57.6K
USD
1
3-6
Months
6.0M
USD
4
6-9
Months
1.7M
USD
2
0-12
Months
4.2M
USD
4
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
15.3K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
60.0K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
3
474.5K
Volume
Months
6-9
4
961.7K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
57.6K
USD
1
3-6
Months
6.0M
USD
4
6-9
Months
1.7M
USD
2
0-12
Months
4.2M
USD
4
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
15.3K
USD
Months
INSP News & Events
Events Timeline
2025-07-23 (ET)
2025-07-23
15:05:45
Apnimed says sleep apnea drug meets primary endpoint in Phase 3 trial
2025-05-06 (ET)
2025-05-06
09:48:56
Inspire Medical falls -11.9%
2025-05-05 (ET)
2025-05-05
17:17:05
Inspire Medical raises FY25 EPS view to $2.20-$2.30 from $2.10-$2.20
Sign Up For More Events
Sign Up For More Events
News
6.5
06-05NASDAQ.COMAnalysts Forecast 19% Gains Ahead For The Holdings of RWJ
1.0
05-30NewsfilterInspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
6.0
05-06BenzingaMorgan Stanley Maintains Overweight on Inspire Medical Systems, Lowers Price Target to $200
Sign Up For More News
People Also Watch
GXO
GXO Logistics Inc
51.770
USD
+0.29%
BIPC
Brookfield Infrastructure Corp
41.650
USD
-0.93%
MGY
Magnolia Oil & Gas Corp
23.980
USD
+1.91%
NSIT
Insight Enterprises Inc
144.450
USD
-1.18%
INTA
Intapp Inc
41.520
USD
-2.31%
FFIN
First Financial Bankshares Inc
36.860
USD
+0.08%
MAIN
Main Street Capital Corp
65.570
USD
+0.21%
FRSH
Freshworks Inc
14.260
USD
-1.59%
AROC
Archrock Inc
23.370
USD
+1.56%
GTES
Gates Industrial Corporation PLC
24.960
USD
-0.04%
FAQ
What is Inspire Medical Systems Inc (INSP) stock price today?
The current price of INSP is 128.64 USD — it has decreased -2.21 % in the last trading day.
What is Inspire Medical Systems Inc (INSP)'s business?
What is the price predicton of INSP Stock?
What is Inspire Medical Systems Inc (INSP)'s revenue for the last quarter?
What is Inspire Medical Systems Inc (INSP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Inspire Medical Systems Inc (INSP)'s fundamentals?
How many employees does Inspire Medical Systems Inc (INSP). have?